Home Categories Biochemical Engineering Cladribine
A2475912

Cladribine , ≥98% , 4291-63-8

Synonym(s):
2CdA, Cladribine;2-Chloro-2ʹ-deoxyadenosine - CAS 4291-63-8 - Calbiochem;2-Chloro-2′-deoxyadenosine;CdA;Cladribine

CAS NO.:4291-63-8

Empirical Formula: C10H12ClN5O3

Molecular Weight: 285.69

MDL number: MFCD00153939

EINECS: 636-978-6

Pack Size Price Stock Quantity
10MG RMB103.20 In Stock
25G RMB159.20 In Stock
50MG RMB336.00 In Stock
100MG RMB399.20 In Stock
250mg RMB743.20 In Stock
1g RMB2432.00 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

Melting point: 181-185 °C(lit.)
alpha  D25 -18.8° (c = 1 in DMF)
Boiling point: 547.6±60.0 °C(Predicted)
Density  2.03±0.1 g/cm3(Predicted)
storage temp.  -20°C
solubility  Slightly soluble in water, soluble in dimethyl sulfoxide, slightly soluble in methanol, practically insoluble in acetonitrile. It shows polymorphism (5.9).
pka 13.75±0.60(Predicted)
form  White solid
color  White to Pale Yellow
λmax 265nm(EtOH aq.)(lit.)
Merck  14,2337
Stability: Store in Freezer
InChIKey PTOAARAWEBMLNO-HSUXUTPPSA-N
CAS DataBase Reference 4291-63-8(CAS DataBase Reference)

Description and Uses

Cladribine, an adenosine deaminase inhibitor, was introduced in the United States as a single intravenous treatment for hairy cell leukemia. The incorporation of a chlorine atom at the 2-position of deoxyadenosine renders cladribine more resistant to enzymatic attack by adenosine deaminase, resulting in a more prolonged cytotoxic effect. Cladribine efficiently crosses lymphocyte and monocyte cell membranes and is metabolized in cells to the biologically active triphosphate, which inhibits DNA synthesis. While most antineoplastic drugs are active primarily against dividing cells, cladribine destroys both resting and proliferating cells. Its potential uses in the treatment of autoimmune hemolytic anemia, multiple sclerosis, chronic lymphocytic leukemia and various lymphomas have also been evaluated.

2-Chloro-2′-deoxyadenosine (2-CdA) is a chlorinated purine nucleoside with activity against lymphoproliferative disorders, such as hairy cell leukemia (HCL) and multiple myeloma (MM). 2-CdA resists ADA degradation and is phosphorylated to CdATP in lymphocytes. CdATP incorporation into DNA induces strand breaks and the activation of apoptosis. 2-CdA may also be used in studies involving the inhibition of DNA polymerase(s).
Cladribiane, like fludarabine, is a prodrug that is must be phosphorylated intracellularly to the monophosphate by the nuclear/cytosol enzyme deoxycytidine kinase (dCK) and possibly by the mitochondrial enzyme deoxyguanosine kinase (dGK).

Safety

Symbol(GHS) 
GHS06,GHS08
Signal word  Danger
Hazard statements  H301-H341-H361fd-H372
Precautionary statements  P201-P202-P260-P264-P270-P301+P310
Hazard Codes  T
Risk Statements  36/37/38-23/24/25
Safety Statements  26-37/39-45-36-22
RIDADR  UN 2811 6.1 / PGIII
WGK Germany  3
RTECS  AU7357560
HS Code  29349990
Hazardous Substances Data 4291-63-8(Hazardous Substances Data)
Toxicity LD50 intraperitoneal in mouse: 150mg/kg

RELATED PRODUCTS